Risk Assessment for On-Site Inspections
Recommendation
5-7 May 2026
Berlin, Germany
Initial and Continuous Professional Training for GMP Auditors
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
Due to the pandemic-related travel restrictions, supervising authorities are currently mostly carrying out so-called distant assessments. However, most inspectorates also carry out partial on-site inspections, sometimes even unannounced.
The PIC/S has now developed a "Covid-19 Risk Assessment for National Routine On-Site Inspections". This risk assessment is based on a FMEA (Failure Mode and Effects Analysis) and should be carried out during the planning phase of the inspection together with the company to be inspected.
Topics to be discussed and assessed include:
- Limitation of possible COVID-19 exposure for inspectors
- Clothing (e.g. it is recommended to take off jewellery and to wear waterproof shoes)
- Cleaning of the workplace and materials used
- National guidelines for face coverings
- General hygiene guidelines
But what about unannounced inspections?
If an unannounced inspection has to take place, an "individual bespoke risk assessment" should be carried out; the assessment suggested in the document should then not be used.
Related GMP News
22.04.2026No Validation, No Controls, and No Suitable Rooms and Equipment - Extensive Warning Letter
25.03.2026FDA Warning Letter highlights once again: Weaknesses in the CAPA Process remain a key GMP Issue
18.03.2026FDA Issues Draft Guidance on Responding to Form 483 Observations
28.01.2026What is the Procedure for GMP Inspections (EU GMP inspections and FDA Inspections)?
21.01.2026FDA Warning Letter highlights critical Failures in Supplier and Quality Oversight
19.01.2026GMP Auditor Association Developments September through December 2025